Diagnovus has announced the launch of a gene expression assay, ENGAUGE-cancer-DLBCL, designed for use in patients with diffuse large B-cell lymphoma (DLBCL). The assay, which combines patients International Prognostic Index (IPI) score ...
Tags: Diagnovus, B-Cell lymphoma, Medicine